Gabapentin in traumatic nerve injury pain: A randomized, double-blind, placebo-controlled, cross-over, multi-center study

Pain

Volumn 138, Issue 2, 2008, Pages 255-266

  Gordh, Torsten E ^a   Stubhaug, Audun ^b   Jensen, Troels S ^c   Arnèr, Staffan ^d   Biber, Björn ^e   Boivie, Jörgen ^f   Mannheimer, Clas ^g   Kalliomäki, Jarkko ^h   Kalso, Eija ⁱ  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Gabapentin; Neuropathic pain; Randomized controlled cross over trial; Traumatic nerve injury

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CODEINE; DEXTROPROPOXYPHENE; GABAPENTIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; OPIATE; PARACETAMOL; PLACEBO; PREGABALIN; SODIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; AMNESIA; ANALGESIA; ARTICLE; ATAXIA; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CRUSH TRAUMA; DIPLOPIA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DYSARTHRIA; ERYTHEMA; FATIGUE; FEMALE; HEADACHE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALAISE; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA AND VOMITING; NEUROPATHIC PAIN; PAIN ASSESSMENT; PERIPHERAL NERVE INJURY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; SLEEP; SURGICAL INJURY; TREATMENT OUTCOME; VERTIGO; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; AMINES; CROSS-OVER STUDIES; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PERIPHERAL NERVES; TRAUMA, NERVOUS SYSTEM;

EID: 43549114363     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2007.12.011     Document Type: Article

References (35)

1. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280 (1998) 1831-1836
2. Chesler E.J., Ritchie J., Kokayeff A., Lariviere W.R., Wilson S.G., and Mogil J.S. Genotype-dependence of gabapentin and pregabalin sensitivity: the pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited. Pain 106 (2003) 325-335
3. Cruccu G., Anand P., Attal N., Garcia-Larrea L., Haanpää M., Jørum E., et al. FENS guidelines on neuropathic pain assessment. Eur J Neurol 11 (2004) 153-162
4. 3H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 295 (2000) 1086-1093
5. Dworkin R.H., Corbin A.E., Young J.P., Sharma U., LaMoreaux L., Bockbrader H., et al. Pregabalin for the treatment of postherpetic neuralgia. Neurology 60 (2003) 1274-1283
6. Dworkin R.H., Turk D.C., Farrar J.T., Haythornthwaite J.A., Jensen M.P., Katz N.P., et al. Core outcome measures for chronic pain clinical trial: IMMPACT recommendations. Pain 113 (2005) 9-19
7. Farrar J.T., Young Jr. J.P., LaMoreaux L., Werth J.L., and Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001) 149-158
8. ++-influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42 (2002) 229-236
9. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289-305
10. 2δ-subunit of a calcium channel. J Biol Chem 271 (1996) 5768-5776
11. Hahn K., Arendt G., Braun J.S., von Giesen H.-J., Husstedt I.W., Maschke M., et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 251 (2004) 1260-1266
12. Jefferson J.W. Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder). J Clin Psychiatry 62 (2001) 235-244
13. Jensen M.P., and Karoly P. Self report scales and procedures for assessing pain in adults. In: Turk D.C., and Melzack R. (Eds). Handbook of pain assessment (2001), Guilford press, New York 15-34
14. Jones B., and Kenward M. Design and analysis of cross-over trials. 2nd Ed. (2003), Chapman & Hall, Boca Raton
15. Kalso E., Allan L., Dellemijn P.L.I., Faura C.C., Ilias W.K., Jensen T.S., et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 7 (2003) 381-386
16. Kalso E., Edwards J.E., Moore R.A., and McQuay H.J. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain (2004) 112-380
17. Karlsten R., and Gordh T. How do drugs relieve neurogenic pain?. Drugs Aging 5 (1997) 398-412
18. Kehlet H., Jensen T.S., and Woolf C.J. Persistent postsurgical pain: risk factors and prevention. Lancet 367 (2006) 1618-1625
19. Levendoglu F., Ögun O., Özerbil O., Ögun T.C., and Ugurlu H. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine 29 (2004) 743-751
20. Lesser H., Sharma U., LaMoreaux L., and Poole R.M. Pregabalin relieves symptoms of painful diabetic neuropathy. Neurology 63 (2004) 2104-2110
21. Meyer-Rosberg K., Kvarnström A., Kinnman E., Gordh T., Nordfors L.O., and Kristofferson A. Peripheral neuropathic pain - a multidimensional burden for patients. Eur J Pain 5 (2001) 379-389
22. Meyerson J., Thelin S., Gordh T., and Karlsten R. The incidence of chronic post-sternotomy pain after cardiac surgery - a prospective study. Acta Anaesthesiol Scand 45 (2001) 940-944
23. Moulin D.E., Iezzi A., Amireh R., Sharpe W.K., Boyd D., and Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 347 (1996) 143-147
24. Pande A.C., Davidson J.R.T., Jefferson J.W., Janney C.A., Katzelnick D.J., Weisler R.H., et al. Treatment of social phobia with gabapentin: a placebo controlled study. J Clin Psychopharmacol 19 (1999) 341-348
25. Pande A.C., Crockett J.G., Feltner D.E., Janney C.A., Smith W.T., Weisler R., et al. Pregabalin in generalized anxiety dis: a placebo-controlled trial. Am J Psychiatry 160 (2003) 533-540
26. Rice A.S.C., and Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 94 (2001) 215-224
27. Rickels K., Pollack M.H., Feltner D.E., Lydiard R.B., Zimbroff D.L., Bielski R.J., et al. Pregabalin for treatment of general anxiety disorder. A 4-week multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry 62 (2005) 1022-1030
28. Rosenstock J., Tuchman M., LaMoreayx L., and Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110 (2004) 628-638
29. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
30. Sabatowski R., Gálvez R., Cherry D.A., Jacquot F., Vincent E., Maisonobe P., et al. Pregabalin reduces and improves sleep and mood disturbances in patients with pot-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 109 (2004) 26-35
31. Serpell M.G. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain 99 (2002) 557-566
32. Sullivan M., and Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 51 (1998) 1005-1113
33. Tiippana E., Nilsson E., and Kalso E. Post-thoracotomy pain after thoracic epidural analgesia: a prospective follow-up study. Acta Anaesthesiol Scand 47 (2003) 433-438
34. Ware J.E., and Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
35. Wheeler G. Gabapentin (Pfizer). Curr Opin Invest Drugs 3 (2002) 470-477